adjuvanted influenza vaccine (Seqirus investigation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for adjuvanted influenza vaccine (Seqirus investigation), covering 2026-06-23 to 2026-06-23. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age [Phase 3]